Case Studies from across the Catapults
- Skills (11),
- Levelling up (18),
- Highlights (27),
- Equality, Diversity and Inclusion (12),
- International (12),
- Academic engagement (19),
- Net Zero (23),
- Health (18),
- Digital technologies (18),
- Business growth (29),
- Supply chains (6),
- Leveraging Investment (19),
Themes
- Cross-Catapult (2),
- Cell and Gene Therapy (17),
- Compound Semiconductor Applications (12),
- Connected Places (15),
- Digital (16),
- Energy Systems (16),
- High Value Manufacturing (18),
- Medicines Discovery (14),
- Offshore Renewable Energy (16),
- Satellite Applications (15),
Catapults (Reset)
Cell and Gene Therapy
Case Study
Upskilling the UK to take full advantage of the potential of cell and gene therapies
Cell and Gene Therapy Catapult is a global leader in skills in a rapidly growing sector. Through a range of initiatives such as the world’s first apprenticeship programme for cell and gene therapies and a national training network it now supports a sector employing almost 7,000 people from across the UK, with the workforce predicted to grow to over 15,000 by 2026.
Cell and Gene Therapy
Case Study
Delivering safer advanced therapies, faster and at lower cost through technology and process innovation
At its core, Cell and Gene Therapy Catapult is an innovation and technology company. Its work with industry in the development of novel processes and analytical techniques for cell and gene therapy manufacture has supported significant investment into startup businesses as well as attracting international manufacturers such as Rentschler to invest in manufacturing in the UK.
Cell and Gene Therapy
Case Study
Establishing Stevenage as a global leader for cell and gene therapies
UK Government invested £72m in the Cell and Gene Therapy Catapult centre in Stevenage. This has led to the creation of one of the leading cell and gene therapy clusters globally and brought £1.5bn to the region through the 45 companies that are now investing there.
Cell and Gene Therapy
Case Study
The Cell and Gene Therapy Catapult: bringing new jobs, investment and long-term business success to Stevenage
Stevenage, which lies about 30 miles north of London, was named the UK’s first ‘New Town’ in 1946.
For many years its population relied on the engineering jobs and skills developed by British Aerospace. But times have changed and today Stevenage stands at the forefront of an entirely new generation of advanced healthcare technology and discovery.
Cell and Gene Therapy
Case Study
Becoming a beacon of equality, diversity and inclusion within the Cell and Gene Therapy sector
Cell and Gene Therapy Catapult prides itself on having a diverse, inclusive and balanced workforce and aims to create an environment where people are fully supported and feel that they can be themselves at work, irrespective of skin colour, age, sexuality and disability.
Cell and Gene Therapy
Case Study
Advancing acute myeloid leukaemia cell therapy
A collaboration between the Cell and Gene Therapy Catapult, University College London and Imperial College London advances a novel cell therapy for the treatment of acute myeloid leukaemia.
Cell and Gene Therapy
Case Study
Developing treatments for chronic kidney disease
University spin-out Purespring Therapeutics sought expert input from the Cell and Gene Therapy Catapult to efficiently progress their pre-clinical development plans and secured one of the largest single investment to a UK biotech company from global healthcare giant Syncona.
Cell and Gene Therapy
Case Study
Pioneering technology to increase effectiveness of gene therapeutics
A collaboration between the Cell and Gene Therapy Catapult and Synpromics set out to develop novel scalable manufacturing processes and technologies to produce viral vectors at scale.
Page 1 of 1